HPC
DGX icon

HM Payson & Co’s Quest Diagnostics DGX Stock Holding History

HM Payson & Co’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718K Sell
3,386
-7,185
-68% -$1.41M 0.01% 263
2026
Q1 		$2.07M Sell
10,571
-680
-6% -$132K 0.03% 160
2025
Q4 		$1.95M Hold
11,251
– – 0.03% 158
2025
Q3 		$2.14M Hold
11,251
– – 0.03% 151
2025
Q2 		$2.02M Hold
11,251
– – 0.03% 149
2025
Q1 		$1.9M Hold
11,251
– – 0.03% 151
2024
Q4 		$1.7M Hold
11,251
– – 0.03% 163
2024
Q3 		$1.75M Sell
11,251
-266
-2% -$39.7K 0.03% 168
2024
Q2 		$1.58M Hold
11,517
– – 0.03% 170
2024
Q1 		$1.53M Sell
11,517
-166
-1% -$21.5K 0.03% 176
2023
Q4 		$1.61M Sell
11,683
-115
-1% -$15.1K 0.03% 163
2023
Q3 		$1.44M Hold
11,798
– – 0.03% 164
2023
Q2 		$1.66M Hold
11,798
– – 0.04% 159
2023
Q1 		$1.67M Sell
11,798
-210
-2% -$30K 0.04% 154
2022
Q4 		$1.88M Hold
12,008
– – 0.05% 143
2022
Q3 		$1.47M Sell
12,008
-330
-3% -$43.5K 0.04% 152
2022
Q2 		$1.64M Sell
12,338
-1,500
-11% -$204K 0.04% 154
2022
Q1 		$1.89M Hold
13,838
– – 0.04% 156
2021
Q4 		$2.39M Buy
13,838
+100
+0.7% +$15.2K 0.05% 152
2021
Q3 		$2M Buy
13,738
+330
+2% +$48.3K 0.05% 159
2021
Q2 		$1.77M Hold
13,408
– – 0.04% 168
2021
Q1 		$1.72M Buy
13,408
+10
+0.1% +$1.23K 0.05% 168
2020
Q4 		$1.6M Hold
13,398
– – 0.04% 168
2020
Q3 		$1.53M Hold
13,398
– – 0.05% 164
2020
Q2 		$1.53M Hold
13,398
– – 0.05% 158
2020
Q1 		$1.08M Hold
13,398
– – 0.04% 165
2019
Q4 		$1.43M Sell
13,398
-80
-0.6% -$8.34K 0.05% 168
2019
Q3 		$1.44M Hold
13,478
– – 0.05% 167
2019
Q2 		$1.37M Hold
13,478
– – 0.05% 169
2019
Q1 		$1.21M Buy
+13,478
New +$1.17M 0.05% 161
2018
Q4 		– Sell
-13,573
Closed -$1.47M – 198
2018
Q3 		$1.47M Buy
13,573
+2,998
+28% +$329K 0.07% 152
2018
Q2 		$1.16M Buy
10,575
+70
+0.7% +$7.29K 0.05% 167
2018
Q1 		$1.05M Sell
10,505
-74
-0.7% -$7.58K 0.04% 174
2017
Q4 		$1.04M Sell
10,579
-11
-0.1% -$1.04K 0.04% 185
2017
Q3 		$992K Hold
10,590
– – 0.04% 183
2017
Q2 		$1.18M Hold
10,590
– – 0.05% 172
2017
Q1 		$1.04M Hold
10,590
– – 0.05% 180
2016
Q4 		$973K Sell
10,590
-36
-0.3% -$3.1K 0.05% 187
2016
Q3 		$899K Buy
10,626
+87
+0.8% +$7.31K 0.04% 189
2016
Q2 		$858K Hold
10,539
– – 0.04% 188
2016
Q1 		$753K Hold
10,539
– – 0.04% 189
2015
Q4 		$750K Sell
10,539
-45
-0.4% -$3.02K 0.04% 194
2015
Q3 		$651K Sell
10,584
-400
-4% -$28K 0.04% 195
2015
Q2 		$797K Hold
10,984
– – 0.04% 190
2015
Q1 		$844K Hold
10,984
– – 0.04% 184
2014
Q4 		$737K Hold
10,984
– – 0.04% 196
2014
Q3 		$667K Hold
10,984
– – 0.03% 198
2014
Q2 		$645K Hold
10,984
– – 0.03% 200
2014
Q1 		$636K Hold
10,984
– – 0.03% 194
2013
Q4 		$588K Sell
10,984
-36
-0.3% -$2.13K 0.03% 197
2013
Q3 		$681K Buy
11,020
+400
+4% +$23.9K 0.04% 191
2013
Q2 		$644K Buy
+10,620
New +$633K 0.04% 185

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

HM Payson & Co's DGX Position: Q2 2026 in Review

HM Payson & Co reduced its Quest Diagnostics (DGX) stake by 68% in Q2 2026, selling an estimated $1.41M and leaving 3,386 shares worth $718K. The position accounts for 0.01% of the portfolio, ranked #263.

HM Payson & Co first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.39M in Q4 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • HM Payson & Co held 3,386 shares of Quest Diagnostics worth $718K as of Q2 2026.
  • HM Payson & Co sold 7,185 Quest Diagnostics shares in Q2 2026, an estimated $1.41M.
  • Quest Diagnostics made up 0.01% of HM Payson & Co's portfolio in Q2 2026, its #263 holding.
  • HM Payson & Co first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • HM Payson & Co's Quest Diagnostics position peaked at $2.39M in Q4 2021.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.